Items where authors include "Stanton, L"

Article

Davies, AJ, Barrans, S, Stanton, L et al. (20 more authors) (2023) Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up. Journal of Clinical Oncology, 41 (15). pp. 2718-2723. ISSN 0732-183X

Davies, A, Cummin, TE, Barrans, S et al. (21 more authors) (2019) Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial. The Lancet Oncology, 20 (5). pp. 649-662. ISSN 1470-2045

Copson, ER, Maishman, TC, Tapper, WJ et al. (21 more authors) (2018) Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study. The Lancet Oncology, 19 (2). pp. 169-180. ISSN 1470-2045

Crabb, SJ, Martin, K, Abab, J et al. (21 more authors) (2017) COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss. European Journal of Cancer, 87. pp. 75-83. ISSN 0959-8049